Health Canada grants production and distribution amended to Optimi Health for pharmaceutical manufacturing
Canadian Manufacturing
AUGUST 16, 2022
Health Canada grants production and distribution amended to Optimi Health for pharmaceutical manufacturing. The Company is scheduled to begin production and analytical testing of MDMA this October in its recently completed EU-GMP pharmaceutical manufacturing facility. VANCOUVER — Optimi Health Corp.,
Let's personalize your content